Investigation on the effect of chamomile 7% on cutaneousside effects of Minoxidil in ?the treatment of male pattern alopecia

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017042420258N41

Enrollment

Registered

2017-05-07

Start date

2017-04-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenic alopecia. Androgenic alopecia

Interventions

Intervention 1: Intervention group: We use Minoxidil 0/5 percent and chamomile 7 percent every 12 hours 1 milliliter ?in intervention group. Intervention 2: Control group: We use Minoxidil 0/5 percent

Treatment - Drugs

Intervention group: We use Minoxidil 0/5 percent and chamomile 7 percent every 12 hours 1 milliliter ?in intervention group.

Control group: We use Minoxidil 0/5 percent every 12 hours 1 milliliter in control group .?

Eligibility

Sex/Gender

Male

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: male pattern alopecia; 18 to 40 years; hair loss severity grading ??2 to 5 Hamilton; less than 10 years Exclusion criteria: use of medical or surgical treatment for hair loss in the past ??6 months; history of heart disease or are taking blood pressure-lowering drugs; ?history of drug allergy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Desquamation. Timepoint: Before and monthly to 6 months. Method of measurement: observation.;Itching. Timepoint: Before and monthly to 6 months. Method of measurement: clinical observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mina Mirnezami

Arak University of Medical Sciences

mirnezamim@yahoo.com+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026